Abbott · 1 day ago
Validation Engineer IV
Abbott is a global healthcare leader that helps people live more fully at all stages of life. They are seeking an experienced Validation Engineer IV to support ongoing validation programs, ensuring compliance with regulatory and quality standards while collaborating with cross-functional teams.
BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical
Responsibilities
Support and execute validation activities in compliance with applicable regulatory and quality standards
Perform critical analysis of validation data and provide recommendations for improvements or corrective actions
Develop, review, and approve validation protocols, reports, and related documentation
Ensure all validation activities are completed according to project timelines and company procedures
Collaborate with cross-functional teams to identify and resolve validation-related issues
Maintain clear, concise communication and documentation throughout all project phases
Qualification
Required
Bachelor's degree in Science, Engineering, or a related field (or equivalent experience)
Minimum of 7 years of experience supporting validation programs in a regulated industry
Strong attention to detail and organizational skills
Excellent problem-solving and analytical abilities
Proven ability to work independently with structured guidance
Strong written and verbal communication skills
Effective follow-up and documentation management capabilities
Benefits
Medical and Prescription Drug Plans
Dental Plan
Vision Plan
Health Savings Account (for High Deductible Health Plans)
Flexible Spending Accounts (Health, Limited Purpose, Dependent Care, Commuter Parking and Commuter Transit)
Supplemental Life Insurance
Short Term Disability (coverage varies by state)
Long Term Disability
Critical Illness, Hospital coverage, Accident Insurance
MetLife Legal, MetLife ID Fraud, and MetLife Pet Insurance
401(k)
Company
Abbott
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Funding
Current Stage
Public CompanyTotal Funding
$6.79M2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO
Recent News
2026-01-07
2025-12-31
Company data provided by crunchbase